Effect of Follicle-stimulating Hormone Receptor Asn680Ser Polymorphism on the Outcomes of Controlled Ovarian Hyperstimulation: an Updated Meta-analysis of 16 Cohort Studies

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2015 Oct 21

PMID 26481502

Citations 19

Authors

Huilin Tang

Yingying Yan

Tiansheng Wang

Ting Zhang

Weilong Shi

Rong Fan

Yao Yao

Suodi Zhai

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study is to evaluate the influence of follicle-stimulating hormone receptor (FSHR) Asn680Ser polymorphism on the ovarian response to exogenous follicle-stimulating hormone (FSH) and clinical outcomes in women undergoing controlled ovarian hyperstimulation (COH).

Methods: A database search was conducted to identify the eligible studies that investigated the effect of FSHR Asn680Ser polymorphism on ovarian response and clinical outcomes. A pooled analysis was performed with the odds ratio (OR) or weighted mean difference (WMD) and their respective 95 % confidence interval (CI) by the STATA software with random effects model.

Results: Sixteen cohort studies comprising a total of 4287 subjects were included. The number of retrieved oocytes was significantly fewer in subjects with the SS genotype at position 680, compared to subjects with the NN or NS genotype (WMD = -1.36, 95 % CI = -1.85 to -0.87). Lack of association was detected between the genotypes (SS genotype vs. NN or NS genotype) and clinical outcomes such as exogenous FSH dose (WMD = 98.96 IU, 95 % CI = -22.33 to 220.24), poor response (OR = 1.08, 95 % CI = 0.71-1.64), ovarian hyperstimulation syndrome (OHSS) (OR = 1.58, 95 % CI = 0.41-6.07), and clinical pregnancy rate (OR = 1.10, 95 % CI = 0.86-1.40). However, poor ovarian response and number of retrieved oocytes were significantly influenced by the Asn680Ser polymorphism in the Asian subjects. In addition, no publication bias was detected.

Conclusion: FSHR Asn680Ser polymorphism might be a significant biomarker for predicting the number of retrieved oocytes and poor response, especially in Asian subjects. Other outcomes such as exogenous FSH dose, OHSS, and pregnancy rate were not influenced by FSHR Asn680Ser polymorphism.

Citing Articles

Bariatric Surgery as a Molecular Modulator: The Role of FSHR Polymorphisms in Enhancing eNOS Expression and Reproductive Hormone Dynamics in Women with Severe Obesity.

Voros C, Mavrogianni D, Bananis K, Karakasis A, Papahliou A, Topalis V Biomedicines. 2025; 13(1).

PMID: 39857651 PMC: 11763328. DOI: 10.3390/biomedicines13010067.

Significance of and gene polymorphisms on clinical outcomes in gonadotropin-releasing hormone antagonist protocol with freeze-all strategy: A case-control study.

Amin J, Sandhya Alle N, Patel A, Prajapathi B, Makwana P, Prakash J Int J Reprod Biomed. 2024; 22(7):539-552.

PMID: 39355311 PMC: 11441282. DOI: 10.18502/ijrm.v22i7.16962.

A Systematic Review of Genetics and Reproductive Health Outcomes: Asian Perspective.

Long C, Benny P, Yap J, Lee J, Huang Z Reprod Sci. 2023; 31(2):309-319.

PMID: 37524971 DOI: 10.1007/s43032-023-01311-y.

Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence.

Palomba S, Costanzi F, Nelson S, Caserta D, Humaidan P Reprod Biol Endocrinol. 2023; 21(1):67.

PMID: 37480081 PMC: 10360244. DOI: 10.1186/s12958-023-01113-6.

Presence of endometrioma decreased blastocyst formation rate but not impair Assisted Reproductive Technology (ART) outcome.

Chang J, Yi Y, Chen Y, Guu H, Kung H, Chen L Arch Gynecol Obstet. 2023; 307(6):2011-2020.

PMID: 37067551 DOI: 10.1007/s00404-023-07036-2.

References

Yan Y, Gong Z, Zhang L, Li Y, Li X, Zhu L . Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study. PLoS One. 2013; 8(10):e78138. PMC: 3805513. DOI: 10.1371/journal.pone.0078138. View

Sudo S, Kudo M, Wada S, Sato O, Hsueh A, Fujimoto S . Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002; 8(10):893-9. DOI: 10.1093/molehr/8.10.893. View

Simoni M, Tempfer C, Destenaves B, Fauser B . Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update. 2008; 14(5):459-84. PMC: 2515090. DOI: 10.1093/humupd/dmn024. View

de Castro F, Moron F, Montoro L, Real L, Ruiz A . Pharmacogenetics of controlled ovarian hyperstimulation. Pharmacogenomics. 2005; 6(6):629-37. DOI: 10.2217/14622416.6.6.629. View

Zhou X, Qian W, Li J, Zhang P, Yang Z, Chen W . Who are at risk for thromboembolism after arthroplasty? A systematic review and meta-analysis. Thromb Res. 2013; 132(5):531-6. DOI: 10.1016/j.thromres.2013.09.005. View

Simoni M, Nieschlag E, Gromoll J . Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update. 2002; 8(5):413-21. DOI: 10.1093/humupd/8.5.413. View

Sheikhha M, Eftekhar M, Kalantar S . Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci. 2011; 4(2):86-90. PMC: 3205539. DOI: 10.4103/0974-1208.86089. View

Terrazzino S, Cargnin S, Del Re M, Danesi R, Canonico P, Genazzani A . DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis. Pharmacogenomics. 2013; 14(11):1255-72. DOI: 10.2217/pgs.13.116. View

Lledo B, Guerrero J, Turienzo A, Ortiz J, Morales R, Ten J . Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics. 2013; 23(5):262-8. DOI: 10.1097/FPC.0b013e32835fe813. View

10.

Behre H, Greb R, Mempel A, Sonntag B, Kiesel L, Kaltwasser P . Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005; 15(7):451-6. DOI: 10.1097/01.fpc.0000167330.92786.5e. View

11.

Mohiyiddeen L, Newman W, Cerra C, McBurney H, Mulugeta B, Roberts S . A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertil Steril. 2012; 99(1):149-155. DOI: 10.1016/j.fertnstert.2012.08.037. View

12.

Mohiyiddeen L, Newman W, McBurney H, Mulugeta B, Roberts S, Nardo L . Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertil Steril. 2012; 97(3):677-81. DOI: 10.1016/j.fertnstert.2011.12.040. View

13.

Perez Mayorga M, Gromoll J, Behre H, Gassner C, Nieschlag E, Simoni M . Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000; 85(9):3365-9. DOI: 10.1210/jcem.85.9.6789. View

14.

Hozo S, Djulbegovic B, Hozo I . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5:13. PMC: 1097734. DOI: 10.1186/1471-2288-5-13. View

15.

Klinkert E, Te Velde E, Weima S, van Zandvoort P, Hanssen R, Nilsson P . FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online. 2006; 13(5):687-95. DOI: 10.1016/s1472-6483(10)60660-8. View

16.

Mohiyiddeen L, Newman W, Cerra C, Horne G, Mulugeta B, Byers H . FSH receptor genotype does not predict metaphase-II oocyte output or fertilization rates in ICSI patients. Reprod Biomed Online. 2013; 27(3):305-9. DOI: 10.1016/j.rbmo.2013.06.005. View

17.

Jun J, Yoon J, Ku S, Choi Y, Hwang K, Park S . Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet. 2006; 51(8):665-670. DOI: 10.1007/s10038-006-0005-5. View

18.

Gearhart J, Coutifaris C . In vitro fertilization, the Nobel Prize, and human embryonic stem cells. Cell Stem Cell. 2011; 8(1):12-5. DOI: 10.1016/j.stem.2010.12.015. View

19.

de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Padilla E, Real L . Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003; 80(3):571-6. DOI: 10.1016/s0015-0282(03)00795-7. View

20.

Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M . Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 1999; 71(5):808-14. DOI: 10.1016/s0015-0282(99)00090-4. View